Delivering Global Media Manufacturing Consistency Through Site-To-Site Equivalency

Process consistency is necessary for safe production of effective biologics. To improve consistency, Thermo Fisher has implemented its global equivalency program across its manufacturing facilities focusing on raw materials sourcing, equipment, manufacturing processes, and finished product testing. Thermo Fisher Scientific produces a range of products like dry powder media, supplements, and cell culture media—including proprietary formulations for customers. Its suppliers go through a strict qualification process, and all manufacturing sites use the same equipment and protocols. All sites are ISO 13485- or ISO 9001-certified, with the Grand Island and Paisley facilities also FDA 21 CFR Part 820-compliant. Quality control analysis is conducted on all media products, testing for factors like pH, sterility, and contamination. Learn more about the global equivalency program and what makes it so effective.